Streetbeat News

Regulatory

HIMS

Hims & Hers Health shares are experiencing a decline, potentially due to the FDA listing Ozempic and Wegovy as available medications.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 7:19 pm

BSX

EW

MDT

Boston Scientific's ACURATE IDE trial results for the ACURATE neo2 Aortic Valve System did not meet the non-inferiority criteria compared to control valves, leading to a 1.66% drop in BSX stock. The trial's results were presented at a major cardiovascular symposium.

Portfolio Pulse from Vandana Singh

October 30, 2024 | 7:08 pm

NVO

Novo Nordisk's diabetes and obesity drugs, Ozempic and Wegovy, are now listed as available by the FDA, potentially ending their shortage status. This could impact compounding pharmacies and patients who rely on compounded versions of these drugs.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 6:52 pm

BTCUSD

Bitwise CIO Matt Hougan predicts Bitcoin could surpass $100,000 by 2025, driven by institutional adoption and ETF inflows. He highlights Bitcoin's lighter regulatory burden and its role as a hedge against inflation. Hougan expects new all-time highs this year, with institutional involvement and fixed supply dynamics as key drivers.

Portfolio Pulse from Murtuza Merchant

October 30, 2024 | 6:29 pm

EIS

ISRA

SPY

USO

The White House has stated that Iran should not respond to Israel's retaliation. If Iran does respond, the U.S. will support Israel. This geopolitical tension could impact various sectors, including energy and defense.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 6:27 pm

GOOG

GOOGL

Alphabet Inc (NASDAQ:GOOG)(NASDAQ:GOOGL) is receiving positive analyst reviews following strong third-quarter results, particularly in cloud, search, and YouTube segments. Analysts have raised price targets, highlighting Alphabet's AI initiatives and cloud growth. However, concerns about AI risks and antitrust issues remain.

Portfolio Pulse from Chris Katje

October 30, 2024 | 6:25 pm

PDD

PDD shares are experiencing a decline due to reports that the European Union will investigate Temu.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 6:02 pm

LI

NIO

XPEV

Chinese EV stocks are declining as China instructs its automakers to stop investing in EU countries that support tariffs on Chinese-built EVs.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 5:59 pm